Objective:
The article presents industry contributors’ views on the continuing role of small molecules alongside newer drug modalities.
Approach:
- Perspectives: The article presents comments from five contributors in biotechnology, drug discovery, and computational science.
- Topics: Contributors discuss oral administration, tissue penetration, intracellular targets, advances in medicinal chemistry and computational methods, protein degraders and macrocycles, manufacturing, and health-system fit.
Key Findings:
- Contributors describe small molecules as continuing to have roles alongside cell therapies, biologics, and RNA-based approaches, with modality choice depending on biological and patient needs.
- Contributors cite oral administration as a potential convenience advantage, particularly for people receiving long-term treatment.
- Contributors describe small molecules as useful for intracellular targets and cite tissue penetration, including access to the central nervous system, as an advantage.
- Contributors discuss advances in medicinal chemistry, computational methods, protein degradation, and work beyond traditional rule-of-five limits as expanding small-molecule research.
- Contributors cite relatively straightforward or scalable manufacturing and the fit of oral medicines with established health-care and reimbursement systems.
Interpretation:
The contributors present small molecules as one modality among several, with their suitability depending on the target and patient needs.
Limitations:
- The supplied context consists of attributed perspectives from industry contributors; it does not provide independent comparative clinical evidence.
- Claims about convenience, access, manufacturing, and modality advantages are presented by contributors and are not independently evaluated in the supplied context.
Conclusion:
The contributors describe small molecules as continuing to have a role and discuss advances they believe are expanding the scope of small-molecule research.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.